NCT00625170View on ClinicalTrials.gov

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Insulin ResistanceDyslipidemia
Interventions
DRUG

olanzapine

olanzapine 10 mg/day for 8 days

DRUG

Haloperidol

haloperidol 3 mg/day for 8 days

Trial Locations (1)

2300 RC

Leiden University Medical Center, Leiden

Sponsors
All Listed Sponsors
collaborator

Dutch Diabetes Research Foundation

OTHER

lead

Leiden University Medical Center

OTHER